Levetiracetam Bluefish

Levetiracetam, the active ingredient in Leleviracetam Bluefish, is an anticonvulsant presented as an oral tablet for oral use. It is employed to treat various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic, and myoclonic seizures.

GNH USA supplies Levetiracetam Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides batch‑tested product for global distribution.

Levetiracetam is an antiepileptic drug that targets seizure activity across several epilepsy syndromes.

- Partial‑onset seizures: reduces seizure frequency in focal epilepsy. - Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. - Myoclonic seizures: decreases myoclonic jerks in appropriate patient populations.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe psychiatric reactions: depression, suicidal thoughts, or aggressive behavior. - Allergic reactions: rash, hives, or angioedema. - Hematologic abnormalities: low blood cell counts such as neutropenia or thrombocytopenia.

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: assess kidney function and adjust dose as needed. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Psychiatric symptoms: observe for mood changes, depression, or aggression. - Pregnancy: discuss potential risks with the prescriber, as safety data are limited. - Concomitant CNS depressants: use caution due to additive sedation. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Alcohol: may increase central nervous system depression. - Carbamazepine: can markedly reduce levetiracetam plasma concentrations.

Moderate Interactions (Monitor Closely): - Valproate: may increase levetiracetam levels, requiring monitoring. - Phenobarbital: may decrease levetiracetam concentrations. - Antidepressants (e.g., SSRIs): monitor for behavioral changes. - Other antiepileptics: assess for additive side‑effects.